Janus Henderson Group’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-11,007
| Closed | -$13.1M | – | 1414 |
|
|
2019
Q2 | $13.1M | Sell |
11,007
-276
| -2% | -$329K | 0.01% | 892 |
|
|
2019
Q1 | $14.1M | Sell |
11,283
-689
| -6% | -$858K | 0.01% | 851 |
|
|
2018
Q4 | $11.3M | Buy |
11,972
+277
| +2% | +$262K | 0.01% | 880 |
|
|
2018
Q3 | $16.8M | Sell |
11,695
-150
| -1% | -$216K | 0.01% | 846 |
|
|
2018
Q2 | $19.1M | Sell |
11,845
-225
| -2% | -$363K | 0.01% | 812 |
|
|
2018
Q1 | $19.6M | Buy |
12,070
+2,292
| +23% | +$3.72M | 0.01% | 797 |
|
|
2017
Q4 | $16.4M | Buy |
9,778
+4,903
| +101% | +$8.23M | 0.01% | 791 |
|
|
2017
Q3 | $6.82M | Sell |
4,875
-141
| -3% | -$197K | ﹤0.01% | 924 |
|
|
2017
Q2 | $5.6M | Buy |
+5,016
| New | +$5.6M | ﹤0.01% | 969 |
|